Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.
- DOI
- 10.1016/s0140-6736(26)00656-2
- Published
- 2026 Jun 6
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-26-00656-2,
title = {Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.},
author = {Horn DB and Aronne LJ and Wharton S and Bays HE and le Roux CW and Srinath R and Gomez-Valderas E and Arad AD and Das S and Dunn JP and Ribeiro A and Glass LC and Lee CJ},
year = {2026},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(26)00656-2},
url = {https://doi.org/10.1016/s0140-6736(26)00656-2}
}RIS
TY - JOUR TI - Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial. AU - Horn DB AU - Aronne LJ AU - Wharton S AU - Bays HE AU - le Roux CW AU - Srinath R AU - Gomez-Valderas E AU - Arad AD AU - Das S AU - Dunn JP AU - Ribeiro A AU - Glass LC AU - Lee CJ PY - 2026 JO - Lancet (London, England) DO - 10.1016/s0140-6736(26)00656-2 UR - https://doi.org/10.1016/s0140-6736(26)00656-2 ER -
APA
DB, H., LJ, A., S, W., HE, B., CW, L. R., R, S., E, G., AD, A., S, D., JP, D., A, R., LC, G., & CJ, L. (2026). Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(26)00656-2
Source records
- pubmed · retrieved 2026-09-27T10:14:56.665Z
- europe-pmc · retrieved 2026-09-27T10:14:56.668Z